ANTI-NMDAR ENCEPHALITIS

Clinical trials for ANTI-NMDAR ENCEPHALITIS explained in plain language.

Never miss a new study

Get alerted when new ANTI-NMDAR ENCEPHALITIS trials appear

Sign up with your email to follow new studies for ANTI-NMDAR ENCEPHALITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Completed 1

Blood-Filtering therapy may tame rare brain inflammation in children

Disease control Completed

This trial investigates whether a blood-filtering procedure called immunoadsorption (IA), combined with the drug rituximab, can improve neurological function in children aged 0-18 with severe anti-NMDAR encephalitis. Participants receive 10 IA sessions over 28 days plus weekly ri…

Matched conditions: ANTI-NMDAR ENCEPHALITIS

Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated Jul 02, 2026 01:00 UTC

ANTI-NMDAR ENCEPHALITIS

Get alerted when new ANTI-NMDAR ENCEPHALITIS trials appear

Blood-Filtering therapy may tame rare brain inflammation in children